Search Results - "Ramos Levi, A."

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients by Rogado, J., Sánchez-Torres, J.M., Romero-Laorden, N., Ballesteros, A.I., Pacheco-Barcia, V., Ramos-Leví, A., Arranz, R., Lorenzo, A., Gullón, P., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondéjar, R., Colomer, R.

“…Cancer immune therapy has shown remarkable benefit in the treatment of a range of cancer types, although it may initiate autoimmune-related disorders in some…”
Get full text

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease by Carrión, M., Ramos-Leví, A. M., Seoane, I. V., Martínez-Hernández, R., Serrano-Somavilla, A., Castro, D., Juarranz, Y., González-Álvaro, I., Gomariz, Rosa P., Marazuela, Mónica

“…Vasoactive intestinal peptide (VIP) is a neuropeptide with potent immunoregulatory properties. Reduced serum VIP levels and alterations in VIP…”
Get full text

Drug-induced hyponatremia: an updated review by Ramos-Levi, A M, Duran Rodriguez-Hervada, A, Mendez-Bailon, M, Marco-Martinez, J

“…Hyponatremia, defined as serum sodium concentrations <135 mmol/L, is the most frequent electrolyte disturbance observed in both hospitalized and ambulatory…”
Get more information

Endoscopic argon plasma coagulation (APC) vs glucagon-like peptide-1 receptor agonists (ARGLP1) liraglutide and semaglutide for the treatment of weight regain (WR) after bariatric surgery (BS) by Mera Carreiro, S., Bernaldo Madrid, B., Rodríguez Carrillo, C., Matía Martín, P., Pérez Ferre, N., Marcuello Foncillas, C., Espinosa de los Monteros Sicilia, P., Ramos Levi, A., Esteban Lopez-Jamar, J.M., Rubio Herrera, M.Á.

Get full text

1287P - Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J., Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A., Pacheco-Barcia, V.E., Garcia, A I Ballesteros, Arranz, R., Lorenzo, A., Gullon, P., Garrido, A., Serra, J.M., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondejar, R., Bosch, R Colomer

“…Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited. Recently, we have…”
Get full text

Excess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J., Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A., Pacheco-Barcia, V.E., Garcia, A I Ballesteros, Arranz, R., Lorenzo, A., Gullon, P., Garrido, A., Serra, J.M., Donnay, O., Adrados, M., Costas, P., Aspa, J., Alfranca, A., Mondejar, R., Bosch, R Colomer

Get full text

1287PExcess weight and efficacy of anti-PD-1 antibodies in advanced cancer patients by Rogado, J, Laorden, N Romero, Torres, J M Sanchez, Ramos-Levi, A, Pacheco-Barcia, V E, Garcia, A I Ballesteros, Arranz, R, Lorenzo, A, Gullon, P, Garrido, A, Serra, J M, Donnay, O, Adrados, M, Costas, P, Aspa, J, Alfranca, A, Mondejar, R, Bosch, R Colomer

“…Abstract Background Immunotherapy is a new and effective form of therapy in several types of cancer, although molecular predictors of response are limited…”
Get full text

Not Available by Ramos-Levi, A M, Pérez-Ferre, N, Sánchez-Pernaute, A, Torres García, A J, Rubio Herrera, M A

Get full text

Síndrome de hipotensión intracraneal espontánea: importancia de los hallazgos en la resonancia magnética by Matías-Guiu Antem, Jordi A., Ramos Leví, Ana, Casas Limón, Javier, Cuadrado Pérez, María Luz, Porta Etessam, Jesús

Get full text

Spontaneous intracranial hypotension syndrome: importance of magnetic resonance findings by Matias-Guiu, J A, Ramos-Levi, A, Casas-Limon, J, Cuadrado-Perez, M L, Porta-Etessam, J

Get full text